Exelixis, Inc.. The Group's principal activity is to develop innovative therapies for cancer and other serious diseases. Its pharmaceutical programs focuses on discovery and development of small molecule drugs for cancer. The Gruoup has built a multidisciplinary, integrated research and development platform that supports the complex, iterative nature of drug discovery, translational research and clinical development. Its first-generation anticancer product candidates in our clinical pipeline are Spectrum Selective Kinase Inhibitors, that have been optimized for balanced potency, specificity, tolerability and pharmacologic parameters. It operates in the United States.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
1,077
Frequently Asked Questions
What is Market Cap of Exelixis Inc?
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Exelixis Inc market cap is $12.61B.
What is the 52-week high for Exelixis Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Exelixis Inc 52 week high is $51.63 as of May 25, 2026.
What is the 52-week low for Exelixis Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Exelixis Inc 52 week low is $33.76 as of May 25, 2026.
What is Exelixis Inc stock price today?
Exelixis Inc stock price today is $50.15.
What was Exelixis Inc stock price yesterday?
Exelixis Inc stock price yesterday was $49.65.
What is the PE ratio of Exelixis Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Exelixis Inc's P/E ratio is 16.62.
What is the Price-to-Book ratio of Exelixis Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Exelixis Inc P/B ratio is 6.5727.
What is the 50-day moving average of Exelixis Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Exelixis Inc 50-day moving average is $45.16.